167 related articles for article (PubMed ID: 35529788)
1. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma.
Guo W; Huai Q; Liu T; Zhang G; Liang N; Ma Q; Liu X; Tan F; Xue Q; Gao S; Gao Y; He J
Transl Lung Cancer Res; 2022 Apr; 11(4):572-587. PubMed ID: 35529788
[TBL] [Abstract][Full Text] [Related]
2. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract][Full Text] [Related]
3. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
[TBL] [Abstract][Full Text] [Related]
4. Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer.
Su Y; Li Y; Guo R; Zhao J; Chi W; Lai H; Wang J; Wang Z; Li L; Sang Y; Hou J; Xue J; Shao Z; Chi Y; Huang S; Wu J
NPJ Breast Cancer; 2021 Dec; 7(1):154. PubMed ID: 34893642
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
6. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
[TBL] [Abstract][Full Text] [Related]
7. Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.
Liao J; Lai H; Liu C; Zhang X; Ou Q; Li Q; Li Y; Wang Z; Liu C; Wu X; Wang H; Yu H; Sun S; Zhao X; Hu Z; Zhang Y; Lin Y; Yu B; Huang S; Wang J
Cancer Sci; 2023 Jul; 114(7):2774-2786. PubMed ID: 37014183
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
9. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma.
Zhang Y; Liu W; Zhang H; Sun B; Chen T; Hu M; Zhou H; Cao Y; Han B; Wu L
Int J Cancer; 2023 Apr; 152(7):1490-1500. PubMed ID: 36451312
[TBL] [Abstract][Full Text] [Related]
11. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
12. Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer.
Liu C; Chen J; Liao J; Li Y; Yu H; Zhao X; Sun S; Hu Z; Zhang Y; Zhu Z; Fan M; Huang S; Wang J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428585
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
14. Plasma Extracellular Vesicle Long RNAs Have Potential as Biomarkers in Early Detection of Colorectal Cancer.
Guo TA; Lai HY; Li C; Li Y; Li YC; Jin YT; Zhang ZZ; Huang HB; Huang SL; Xu Y
Front Oncol; 2022; 12():829230. PubMed ID: 35480120
[TBL] [Abstract][Full Text] [Related]
15. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Li W; Liu S; Su S; Chen Y; Sun G
PeerJ; 2021; 9():e10470. PubMed ID: 33510968
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
18. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
20. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
